Amedica, a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce its participation in the 2016 Brazilian Spine Congress occurring March 3 and 4, 2016 in Sao Paulo, Brazil.
“Brazil has been an emerging growth opportunity for us since achieving clearance during the third quarter of last year thanks in part to our Brazilian partner, Sintex Medical,” said Dr. Sonny Bal, Chairman and CEO. “We feel that the content we plan to present, and the surgeons with whom we will be meeting in Sao Paulo, will strengthen this additional sales channel through the balance of this year.”
“With the limited options currently available to Brazilian surgeons, Brazil reflects a market opportunity for new technologies in spinal products and surgical techniques,” said Daniel Bolotnicki, CEO of Sintex Medical. “We’ve experienced very positive feedback with the silicon nitride fusion devices since our initial launch last quarter, due in part to the unique osteoconductive, anti-infective and superior imaging properties of silicon nitride. We anticipate further geographic expansion, and expect to capture a significant share of the market from legacy PEEK cages that have inherent limitations. We are confident the Brazilian market will understand the superiority of silicon nitride, in terms of positively affecting patient outcomes.”
“I look forward to presenting and sharing the clinical outcomes I’ve experienced while using silicon nitride the past several years,” said Dr. Graham C. Calvert, M.D., Mississippi Sports Medicine and Orthopedic Center. “Silicon nitride truly is a breakthrough material and contains a unique surface biochemistry which ensures reliable osseointegration, while also inhibiting bacterial biofilm adhesion.”
The 16th annual Brazilian Spine Congress attracts leading clinicians, surgeons and scientists from the Americas who come together to present the latest innovative musculoskeletal clinical and scientific research.